World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT01799460
Date of registration: 08/01/2013
Prospective Registration: No
Primary sponsor: Shanghai University of Traditional Chinese Medicine
Public title: Study on Single-nucleotide-polymorphism in Idiopathic Membranous Nephropathy
Scientific title: Mechanism Research of Traditional Chinese Medicine (the Comprehensive Treatment Regimen) in Treating Idiopathic Membranous Nephropathy by Genomewide Association Studies
Date of first enrolment: December 2010
Target sample size: 80
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT01799460
Study type:  Observational
Study design:  Observational Model: Cohort, Time Perspective: Retrospective  
Phase:  N/A
Countries of recruitment
China
Contacts
Name:     Wang Lin, PHD
Address: 
Telephone: 86-13816583673
Email: happytlynn@163.com
Affiliation: 
Name:     Wang Lin, PHD
Address: 
Telephone: 86-13816583673
Email: happytlynn@163.com
Affiliation: 
Name:     Wang Lin, PHD,MD
Address: 
Telephone:
Email:
Affiliation:  Shanghai University of Traditional Chinese Medicine
Key inclusion & exclusion criteria

Inclusion Criteria:

- Clinical diagnosis of idiopathic membranous nephropathy

- Chronic Kidney Disease (CKD)=3 stage(Glomerular Filtration Rate (GFR)=30ml/min)and 24
hour urinary protein=3g

- Voluntarily participated in the study and signed an informed consent

Exclusion Criteria:

- Combined life-threatening complications such as serious infection

- Abnormal glucose metabolism

- Patients with malignant tumors or malignancy , HIV infection and a history of mental
illness , acute central nervous system disease , serious gastrointestinal
diseases,etc

- Pregnancy or breast-feeding women

- Undergoing other clinical trials



Age minimum: 18 Years
Age maximum: 70 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Idiopathic Membranous Nephropathy
Intervention(s)
Drug: The immunosuppressive agents
Drug: The Comprehensive Treatment Regimen of Traditional Chinese Medicine
Primary Outcome(s)
Genome-wide single-nucleotide-polymorphism of IMN patients treated by the Comprehensive Treatment Regimen or conventional approach [Time Frame: one year]
Secondary Outcome(s)
Secondary ID(s)
11YZ65
ShanghaiMEC-2011
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history